Vigil Neuroscience Inc.

NASDAQ: VIGL · Real-Time Price · USD
8.05
0.00 (0.00%)
At close: Aug 04, 2025, 3:59 PM

Vigil Neuroscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
452K 452K 452K 1.93M 1.93M 1.93M 1.93M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
238K 351K 340K 453K 449K 810K 1.08M 1.24M 1.38M 1.16M 1.01M 736K 634K 388K 151K 151K n/a n/a
Gross Profit
-12K -125K -114K 1.48M 1.49M 1.12M 854K -1.24M -1.38M -1.16M -1.01M -736K -634K -388K -151K -151K n/a n/a
Operating Income
-96.75M -91.74M -89.68M -88.43M -90.07M -89.51M -88.87M -83.88M -79.2M -74.33M -68.88M -62.99M -56.09M -49.82M -42.41M -33.49M -45.91M -35.51M
Interest Income
3.75M 5M 5.42M 5.82M 6.24M 6.73M 6.24M 4.99M 3.32M 1.61M 623K 197K 34K 3K 3K 3K 3K 2K
Pretax Income
-92.17M -86.73M -84.26M -82.6M -83.84M -82.78M -82.64M -78.92M -75.92M -72.77M -68.31M -62.83M -56.07M -50.43M -43.28M -34.53M -48.1M -37.12M
Net Income
-92.17M -86.73M -84.26M -82.6M -83.84M -82.78M -81.59M -45.08M -41.95M -38.77M -35.35M -62.67M -56.05M -50.43M -43.28M -34.53M -48.1M -37.12M
Selling & General & Admin
30.39M 27.13M 27.15M 27.67M 27.67M 27.85M 27.82M 27.54M 25.48M 23.41M 21.44M 18.62M 16.7M 13.88M 10.08M 7.1M 5.07M 3.13M
Research & Development
66.36M 64.49M 62.31M 60.42M 62.06M 61.43M 60.93M 56.34M 53.72M 50.91M 47.44M 44.37M 39.39M 35.94M 32.33M 26.39M 40.84M 32.39M
Other Expenses
n/a -3K -5K -3K -6K -10K -13K -24K -47K -45K -44K -43K -19K -14K -10K -2K n/a n/a
Operating Expenses
96.75M 91.62M 89.46M 88.09M 89.73M 89.28M 88.75M 83.88M 79.2M 74.33M 68.88M 62.99M 56.09M 49.82M 42.41M 33.49M 45.91M 35.51M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1K 3K 3K 3K 2K
Selling & Marketing Expenses
n/a -113K -226K -339K -339K -226K -113K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
69.26M 91.74M 89.68M 88.43M 90.07M 89.51M 88.87M 83.88M 79.2M 74.33M 68.88M 62.99M 56.09M 49.82M 42.41M 33.49M 45.91M 35.51M
Income Tax Expense
n/a n/a 69.72K 69.72K -40.28K -40.28K -1.16M -33.95M -33.97M -34M -32.95M -162K -23K 4K 2K 2K n/a n/a
Shares Outstanding (Basic)
47.62M 46.07M 41.66M 40.58M 40.56M 39.86M 38.83M 38.81M 38.66M 38.55M 38.48M 33.3M 28.15M 26.66M 28.26M 28.26M 21.06M 21.06M
Shares Outstanding (Diluted)
47.62M 46.07M 41.66M 40.58M 40.56M 39.86M 38.83M 38.81M 38.66M 38.55M 38.48M 33.3M 28.15M 26.66M 28.26M 28.26M 21.06M 21.06M
EPS (Basic)
-2.09 -2.05 -2.06 -2.06 -2.12 -2.12 -2.11 -1.17 -1.16 -1.24 -1.33 -2.16 -2.02 -1.96 -1.77 -1.51 -2.28 -1.75
EPS (Diluted)
-2.09 -2.05 -2.06 -2.06 -2.12 -2.12 -2.11 -1.17 -1.16 -1.24 -1.33 -2.16 -2.02 -1.96 -1.77 -1.51 -2.28 -1.75
EBITDA
-96.52M -91.4M -89.23M -87.97M -89.62M -89.06M -88.47M -83.58M -78.98M -74.2M -68.81M -62.92M -56.03M -49.78M -34.46M -21.5M -34.7M -24.31M
EBIT
-68.2M -90.68M -89.68M -88.43M -90.07M -89.51M -88.87M -83.88M -79.2M -74.33M -68.88M -62.99M -56.09M -49.82M -42.41M -33.49M -46.68M -36.29M
Depreciation & Amortization
351K 464K 453K 453K 449K 810K 1.08M 1.24M 1.38M 1.16M 1.01M 751K 649K 404K 8.09M 12.13M 14.21M 14.21M